Even at an AZD1775 concentration of just 100nM, caspase 3 displayed an upward trend in all endometrial cancer cell lines, suggesting that AZD1775 can induce tumor cell apoptosis to exert antitumor effects, even at relatively low concentrations. The gene discussed is CASP3; the disease is endometrial cancer.